Key result
Comorbid type 2 diabetes in chronic kidney disease was associated with significantly higher α2 long-term fluctuations in detrended fluctuation analysis at night compared to non-diabetic patients (0.58 vs 0.45).
Why the study?
Patients with CKD are at risk of developing CVD, prompting a pilot to facilitate out-of-clinic evaluation using wearable device-based analysis of heart rate variability and behavioral readouts.
Can wearable device-based analysis of heart rate variability and behavioral readouts differentiate disease phenotypes in patients with chronic kidney disease?
Observational (n=49)
Yes
Can wearable device-based analysis of heart rate variability and behavioral readouts differentiate disease phenotypes in patients with chronic kidney disease?
Absolute Event Rate: 0.58% vs 0.45%
p-value: p=0.004
Wearable device-based analysis of heart rate variability can detect loss of rhythmic organization and differentiate between diabetic and non-diabetic phenotypes in patients with chronic kidney disease.
Supports wearable nocturnal HRV analysis for phenotyping diabetic CKD; hypothesis-generating and should not yet change practice.
Patients with chronic kidney disease (CKD) are at risk of developing cardiovascular disease. To facilitate out-of-clinic evaluation, we piloted wearable device-based analysis of heart rate variability and behavioral readouts in patients with CKD participating in the Chronic Renal Insufficiency Cohort and (n=49) controls. Time-specific partitioning of HRV readouts indicate higher parasympathetic nervous activity during the night (mean RR at night 14.4±1.9 ms versus 12.8±2.1 ms during active hours; n=47, ANOVA q=0.001). The α2 long-term fluctuations in the detrended fluctuation analysis, a parameter predictive of cardiovascular mortality, significantly differentiated between diabetic and non-diabetic patients (prominent at night with 0.58±0.2 versus 0.45±0.12, respectively, adj. p=0.004). Both diabetic and nondiabetic CKD patients showed loss of rhythmic organization compared to controls, with diabetic CKD patients exhibiting deconsolidation of peak phases between their activity and SDNN (standard deviation of interbeat intervals) rhythms (mean phase difference CKD 8.3h, CKD/T2DM 4h, controls 6.8h). This work provides a roadmap toward deriving actionable clinical insights from the data collected by wearable devices outside of highly controlled clinical environments.
No takes yet. Share an insight, caveat, or question.
Lahens et al. (2022) conducted an observational in Chronic Kidney Disease (n=49). Type 2 diabetes mellitus in patients with chronic kidney disease vs. Chronic kidney disease without type 2 diabetes was evaluated on α2 long-term fluctuations in detrended fluctuation analysis (α2-DFA) at night (p=0.004). Comorbid type 2 diabetes in chronic kidney disease was associated with significantly higher α2 long-term fluctuations in detrended fluctuation analysis at night compared to non-diabetic patients (0.58 vs 0.45).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: